In our experience, neither the best cutoff point of baseline sKL-6 nor peak sKL-6 during hospitalization shows an acceptable AUC that would allow us to consider KL-6 as a potential biomarker for predicting respiratory deterioration in patients with mild to moderate COVID-19. The gene discussed is MUC1; the disease is COVID-19.